Most cited papers from Gilead Sciences (Canada)

Gilead Sciences (Canada)

What are the most cited papers from Gilead Sciences (Canada)?

The most cited paper from Gilead Sciences (Canada) is "Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults" (Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier et al., 2001), with 335 citations. Next come "Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA" (325) and "Management of adverse events associated with idelalisib treatment: expert panel opinion" (312).

Published TypeFieldAccessCitations

Showing 50 of 99 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier et al. · Antimicrobial Agents and Chemotherapy Open access	Oct 2001	335
2	Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA Brian L. Robbins, Ranga V. Srinivas, Choung Kim et al. · Antimicrobial Agents and Chemotherapy Open access	Mar 1998	325
3	Management of adverse events associated with idelalisib treatment: expert panel opinion Steven E. Coutre, Jacqueline C. Barrientos, Jennifer R. Brown et al. · Leukemia & lymphoma/Leukemia and lymphoma Open access	2 Mar 2015	312
4	ACG Clinical Guideline: Liver Disease and Pregnancy Tram T. Tran, Joseph C. Ahn, Nancy S. Reau · The American Journal of Gastroenterology	Feb 2016	309
5	Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC) Kalyan Kumar Das, Xiao‐Feng Xiong, Huiling Yang et al. · Journal of Virology Open access	15 May 2001	276
6	Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores Alexandra L. Quittner, Anne E. O’Donnell, Matthias A. Salathe et al. · Thorax	16 Oct 2014	218
7	Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome Eric G. Meissner, David Wu, Anu O Osinusi et al. · Journal of Clinical Investigation Open access	Jul 2014	203
8	A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress Katie R. Martin, Stephanie L. Celano, Abigail R. Solitro et al. · iScience Open access	20 Sep 2018	194
9	Safety, Pharmacokinetics, and Antiretroviral Activity of Intravenous 9-[2-( R )-(Phosphonomethoxy)propyl]adenine, a Novel Anti-Human Immunodeficiency Virus (HIV) Therapy, in HIV-Infected Adults Steven G. Deeks, Patricia Barditch‐Crovo, Paul S. Lietman et al. · Antimicrobial Agents and Chemotherapy Open access	Sep 1998	159
10	NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022 Peter L. Greenberg et al. · Journal of the National Comprehensive Cancer Network Open access	Feb 2022	127
11	Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy Chunkit Fung, Howard D. Sesso, AnnaLynn M. Williams et al. · Journal of Clinical Oncology Open access	27 Feb 2017	109
12	Disruption of nNOS‐PSD95 protein–protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents SK Florio, Christine Loh, S-M Huang et al. · British Journal of Pharmacology Open access	28 Aug 2009	107
13	Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis David L. MacLeod, Levi M. Barker, Judith L. Sutherland et al. · Journal of Antimicrobial Chemotherapy Open access	13 Aug 2009	101
14	Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies Kamal D. Puri, Michael R. Gold · Frontiers in Immunology Open access	2012	101
15	Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia Partow Kebriaei et al. · Transplantation and Cellular Therapy Open access	2 Dec 2017	98
16	Induction of prolonged early G1arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1 David Chiron, Peter Martin, Maurizio Di Liberto et al. · Cell Cycle Open access	15 Jun 2013	72
17	Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis Patrick A. Flume, John Paul Clancy, George Z. Retsch‐Bogart et al. · Journal of Cystic Fibrosis Open access	24 May 2016	58
18	Mono‐ and Difluorination of Benzylic Carbon Atoms Ana Koperniku, Hongqiang Liu, Paul B. Hurley · European Journal of Organic Chemistry	15 Jan 2016	56
19	Inhibition of Duck Hepatitis B Virus Replication by 9-(2-Phosphonylmethoxyethyl)adenine, an Acyclic Phosphonate Nucleoside Analogue Amanda Nicoll, Danni Colledge, J J Toole et al. · Antimicrobial Agents and Chemotherapy Open access	Dec 1998	56
20	Duration of action of hypertonic saline on mucociliary clearance in the normal lung William D. Bennett, Jichuan Wu, Fred Fuller et al. · Journal of Applied Physiology Open access	24 Apr 2015	55
21	Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions Quentin Mark Anstee, Kate Hallsworth, Niall Lynch et al. · JHEP Reports Open access	22 Nov 2021	53
22	Inhibition of PI3Kδ Reduces Kidney Infiltration by Macrophages and Ameliorates Systemic Lupus in the Mouse Abel Suárez‐Fueyo, José Manuel Rojas, Ariel Ernesto Cariaga-Martínez et al. · The Journal of Immunology	17 Jun 2014	52
23	Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411 Thomas G. O’Riordan, Karl H. Donn, Peter Hodsman et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery	Aug 2013	52
24	Pharmacogenomics in the era of next generation sequencing – from byte to bedside Laura E. Russell, Yitian Zhou, Ahmed A. Almousa et al. · Drug Metabolism Reviews Open access	3 Apr 2021	49
25	Eradication ofPseudomonas aeruginosabiofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination Gregory G. Anderson, Thomas F. Kenney, David L. MacLeod et al. · Pathogens and Disease Open access	13 Dec 2012	49
26	Impact of Anti-Drug Antibodies in Preclinical Pharmacokinetic Assessment Theingi M. Thway, Ivan Magana, Ami Bautista et al. · The AAPS Journal Open access	7 May 2013	46
27	Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts Stacey L. Tannheimer, Clifford D. Wright, Michael A Salmon · Respiratory Research Open access	2012	42
28	A Multicenter Phase I/II Dose Escalation Study of Single-Dose Cidofovir Gel for Treatment of Recurrent Genital Herpes Stephen L. Sacks, Stephen D. Shafran, Francisco Díaz‐Mitoma et al. · Antimicrobial Agents and Chemotherapy Open access	Nov 1998	40
29	Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso Nicholas McNamee et al. · Journal of Thoracic Oncology Open access	28 Nov 2023	37
30	Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis Friedrich Horak, Kamal D. Puri, Bart H. Steiner et al. · Journal of Allergy and Clinical Immunology Open access	24 Feb 2016	35
31	A Tandem Enzymatic sp2‐C‐Methylation Process: Coupling in Situ S‐Adenosyl‐ l ‐Methionine Formation with Methyl Transfer Joanna C. Sadler, Luke Humphreys, Radka Šnajdrová et al. · ChemBioChem Open access	31 Mar 2017	32
32	Study of Marine Natural Products Including Resorcyclic Acid Lactones from Humicola fuscoatra That Reactivate Latent HIV-1 Expression in an in Vitro Model of Central Memory CD4+ T Cells Eric J. Mejia, Steven T. Loveridge, George J. Stepan et al. · Journal of Natural Products Open access	4 Feb 2014	28
33	Discriminating sputum-eosinophilic asthma: Accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN Deepak Khatry, David L. Gossage, Gregory P. Geba et al. · Journal of Allergy and Clinical Immunology Open access	25 Apr 2015	27
34	Cell Lines as Biological Models: Practical Steps for More Reliable Research Amanda Capes‐Davis, Amos Bairoch, Tanya Barrett et al. · Chemical Research in Toxicology Open access	15 Jun 2019	26
35	Estimation of C-Index for Cox Proportional Hazards Model with Censored Biomarker Covariate Subject to Limits of Detection Yeonhee Kim, Lan Kong · Journal of Biopharmaceutical Statistics	4 Jun 2014	21
36	Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor Emily E. Way, Giraldina Trevejo-Nuñez, Larry Kane et al. · Scientific Reports Open access	27 Jul 2016	20
37	Single-Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1 Walter T. Hughes, Jerry L. Shenep, John H. Rodman et al. · Antimicrobial Agents and Chemotherapy Open access	Apr 2000	20
38	Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis Steve Kanters, Graeme Ball, Brad S. Kahl et al. · BMC Cancer ReviewOpen access	23 Jan 2023	19
39	Differentiating the Cochran‐Armitage Trend Test and Pearson's χ2 Test: Location and Dispersion Zhengyang Zhou, Hung‐Chih Ku, Zhipeng Huang et al. · Annals of Human Genetics Open access	27 Jun 2017	17
40	A double-blind, multinational, randomized, placebo-controlled trial evaluating aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF), mild lung disease and P. aeruginosa (PA) Claire Elizabeth Wainwright, C. Nakamura, David E. Geller et al. · Journal of Cystic Fibrosis Open access	Jun 2010	17
41	Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada Graeme Ball, Christopher Lemieux, David A. Cameron et al. · Current Oncology Open access	17 Mar 2022	14
42	Rational Drug Development for Mucous Dehydration and Mucous Metaplasia Thomas G. O’Riordan · Journal of Aerosol Medicine and Pulmonary Drug Delivery	14 May 2015	14
43	Advances in the study of drug metabolism – symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX) Laura E. Russell, Mary Alexandra Schleiff, Eric R. Gonzalez et al. · Drug Metabolism Reviews Open access	26 May 2020	13
44	Postinoculation PMPA Treatment, but Not Preinoculation Immunomodulatory Therapy, Protects against Development of Acute Disease Induced by the Unique Simian Immunodeficiency Virus SIVsmmPBj Shekema Hodge, Juliette de Rosayro, Amanda Glenn et al. · Journal of Virology Open access	Oct 1999	13
45	Inhaled Lidocaine for the Treatment of Asthma: Lack of Efficacy in Two Double-Blind, Randomized, Placebo-Controlled Clinical Studies Tammy Abuan, M. L. Yeager, A. Bruce Montgomery · Journal of Aerosol Medicine and Pulmonary Drug Delivery	19 Oct 2010	12
46	Enzyme Optimization and Process Development for a Scalable Synthesis of (R)-2-Methoxymandelic Acid Mark E. Scott, Xiaotian Wang, Luke Humphreys et al. · Organic Process Research & Development	12 Aug 2021	11
47	Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907) Jusheng An, Guiling Li, Yunyan Zhang et al. · Gynecologic Oncology Open access	22 Sep 2025	10
48	Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada Véronique Baribeau, Connie J. Kim, René-Pierre Lorgeoux et al. · PLoS ONE Open access	11 Jul 2022	10
49	Efficacy of Aztreonam Lysine for Inhalation (AZLI) in patients with cystic fibrosis and drug resistant P. aeruginosa (DRPA) Karen McCoy, George Z. Retsch‐Bogart, R.L. Gibson et al. · Journal of Cystic Fibrosis Open access	Jun 2009	10
50	The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada Christopher Hillis, Colin Vicente, Graeme Ball · PharmacoEconomics	18 Jul 2022	9

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.